Affectis Pharmaceuticals
Dortmund
About Affectis Pharmaceuticals
Affectis is a pharmaceuticals company developing novel drugs for the treatment of neurodegenerative and neuroinflammatory diseases.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $10K – $50K
- Total funding: $24.4M
- Funding stage: M&A
- Last round: Series D (Mar 2010)
- Website: affectis.com
- Phone: +4968949396851
Industries & Categories
Biopharma, Biotechnology, Health Care, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/affectis-pharmaceuticals-683469 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.